Buscar resultados de ensayos clínicos
Primary Central Nervous System Lymphoma - 27 Studies Found
| Estado | Estudiar |
| Recruiting |
Nombre del estudio: Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma Condición: Lymphoma Fecha: 1999-11-01 Intervenciones:
|
| Completed |
Nombre del estudio: Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma Condición: Lymphoma Fecha: 2000-09-11 Intervenciones:
|
| Withdrawn |
Nombre del estudio: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Condición: Lymphoma Fecha: 1999-11-01 Intervenciones:
|
| Completed |
Nombre del estudio: Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma Condición: Lymphoma Fecha: 2003-12-10 Intervenciones:
|
| NOT_YET_RECRUITING |
Nombre del estudio: Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study Condición: Fecha: 2024-11-21 Intervenciones: 1.8 Gy of 4-6 MV X-ray to a total dose of 23.4 Gy (13 fractions) will be delivered. |
| RECRUITING |
Nombre del estudio: Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas Condición: Primary Central Nervous System Lymphoma Fecha: 2024-11-21 Intervenciones: Participants will receive 900 mg/m^2 via IV infusion over 10 minutes every 3 weeks x 4-8 induction cycles (21 days per cycle) as part of the indu |
| COMPLETED |
Nombre del estudio: First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen) Condición: Primary Central Nervous System Lymphoma Fecha: 2024-11-21 Intervenciones: The subjects received ORM regimen treatment every 21 days for a total of 6 cycles.The specific medication is as follows " Obutinib tablets |